Document:

Memorandum of Understanding

 Exhibit 10.1 
 MEMORANDUM OF UNDERSTANDING 
 This Memorandum of Understanding (“Memorandum”) is
made and entered into between and among (i) California Public Employees’ Retirement System (“CalPERS”), Alaska Plumbing and Pipefitting Industry Pension Trust (“Alaska Plumbing”) (for themselves and on behalf of all
persons who purchased or otherwise acquired the publicly traded securities of UnitedHealth Group Inc. (“UnitedHealth”) between January 20, 2005 and May 17, 2006 (“Class Members”)) (collectively, the
“Plaintiffs”); and (ii) UnitedHealth, and Stephen J. Hemsley, Patrick J. Erlandson, Robert J. Sheehy, William A. Munsell, Tracy L. Bahl, Lois E. Quam, James A. Johnson, Thomas H. Kean, Mary O. Mundinger, William C. Ballard, Douglas W.
Leatherdale, William G. Spears, Gail R. Wilensky, Richard T. Burke, Donna E. Shalala, and Robert L. Ryan (collectively the “Individual Defendants”) (together with UnitedHealth, the “Settling Defendants”). Defendants William W.
McGuire and David J. Lubben (collectively, the “Non-Settling Defendants”) are not parties to this Memorandum and are not Settling Defendants. 
 The Plaintiffs and the Settling Defendants (collectively, the “Settling Parties”) have reached an agreement in principle for the settlement of the securities class action captioned In re UnitedHealth
Group Incorporated PSLRA Litigation, Civil Action No. 06-1691 JMR/FLN (the “Consolidated Action”) pending in the United States District Court, District of Minnesota (the “Court”), as between the Settling Parties, on the
terms set forth below and subject to Court approval. This Memorandum outlines the principal terms of the settlement (“Settlement”) and is intended to be used as a basis for drafting a Stipulation of Settlement (“Stipulation”) to
be executed by, or on behalf of the Settling Parties, and accompanying papers that shall embody the terms set forth herein and such other consistent terms as agreed upon by the Settling Parties. 
 1. Settlement Sum. UnitedHealth shall pay the settlement sum of $895,000,000 (the “Settlement Sum”). $450,000,000 of the Settlement Sum
(“First Installment”) will be deposited into an interest-bearing escrow account controlled by Plaintiffs’ Lead Counsel 

 
(“Lead Counsel”) and subject to the Court’s oversight (the “Settlement Account”) by wire transfer according to the instructions to
be supplied by Plaintiffs, by the earlier of (i) ten (10) days following the date the Court preliminarily approves the terms of the Settlement (“Preliminary Approval”); or (ii) September 15, 2008. UnitedHealth will
deposit the remainder of the Settlement Sum, that is $445,000,000, (“Second Installment”) into the Settlement Account, upon the earlier of: (i) ten (10) days following the date the Court gives its final approval of the Settlement
and enters a Partial Final Judgment and Order of Dismissal with prejudice (“Partial Final Judgment”) and the Partial Final Judgment is affirmed on appeal and/or is no longer subject to appeal or certiorari, and the time for any petition
for reargument, appeal, or review, by certiorari or otherwise, has expired; (ii) ten (10) days following execution by Plaintiffs and both Non-Settling Defendants of a Memorandum of Understanding that contains an agreement in principle for
the settlement of the Consolidated Action, as between the Plaintiffs and Non-Settling Defendants; or (iii) January 1, 2009. The principal amount of the Second Installment shall bear interest from the date of the deposit of the First
Installment until paid at four and one half (4.5) percent. No funds are to be paid or withdrawn from the Settlement Account absent a Court order, except as is consistent with the terms of the Settlement for the payment of notice and Settlement
administration, taxes on the Settlement Sum, and tax form preparation, or as otherwise to be provided in the Stipulation. 
 2. Corporate
Governance Improvements. No later than thirty (30) days after the Partial Final Judgment is entered by the Court, UnitedHealth will implement the corporate governance changes set forth in Exhibit A hereto, which changes were the product of
substantial and lengthy negotiations between the Settling Parties, and shall be maintained for a period of no less than five (5) years. Defendants also acknowledge that the pendency and prosecution of the Consolidated Action, including the
demands made in connection therewith, were a contributing 

  

 2 

 
factor underlying the decision of the UnitedHealth Board to substantially alter and improve the manner in which UnitedHealth is governed by adopting the
additional corporate governance changes briefly summarized in Exhibit B hereto, via modification of UnitedHealth’s bylaws and Principles of Governance. 
 3. Non-Recapture. The Settlement will be non-recapture, i.e., it is not a claims-made settlement. The Settling Defendants have no ability to have returned to them any of the Settlement Sum; provided,
however, that if the Settlement fails to receive court approval, or the Settlement fails for any other reason, then the Settlement Sum paid (including any interest earned on such payments), less taxes paid or owed, tax preparation fees and costs of
notice and claims administration paid or incurred, shall promptly be returned to UnitedHealth. The settlement claims process will be administered by an independent claims administrator selected by Lead Counsel and appointed by the Court. The
Settling Defendants will have no involvement in reviewing or challenging claims. Costs of notice of the Settlement and administration and distribution costs shall be paid out of the Settlement Account. Settling Defendants shall have no
responsibility or liability for the plan of allocation to Class Members. 
 4. Payment of Attorneys’ Fees and Expenses. Any
attorneys’ fees and expenses awarded Plaintiffs’ counsel by the Court shall be paid to Plaintiffs’ Lead Counsel within three (3) business days of the entry of the Partial Final Judgment by the Court, notwithstanding the existence
of any timely filed objections thereto, or potential for appeal therefrom, or collateral attack on the Settlement or any part thereof, subject to Plaintiffs’ counsel’s joint and several obligations to make appropriate refunds or repayments
to the Settlement Sum plus interest earned thereon if, and when, as the result of any appeal and/or further proceedings on remand, or successful collateral attack, the fee or expense award is reduced or reversed. Plaintiffs’ counsel shall make
the appropriate refund or repayment, in full, 

  

 3 

 
within ten (10) days following any such reduction of the fee or cost award, or the termination of the Settlement. The obligation to make appropriate
refund or repayment may be enforced by the Court. The Settlement Sum shall be the sole source of payment of any award of attorneys’ fees and expenses to Plaintiffs’ counsel. The Settling Parties agree that the denial, in whole or in part,
of any application for attorneys’ fees and expenses shall in no way affect the enforceability, validity or finality of the Settlement. 
 5. Termination Option. UnitedHealth has the right, within twenty (20) days from the expiration of the opt-out period established by the Court, at its option, to terminate and cancel the Settlement if the persons or entities
who would otherwise be Class Members, but who exclude themselves from the Settlement in accordance with the terms of the notice, purchased, acquired or held shares (that would otherwise be entitled to damages) that collectively exceed five
(5) percent of the number of damaged shares as estimated in Plaintiffs’ Expert Opening Report. The procedure, terms and conditions for exercising this option will be set forth in the Stipulation. 
 6. Mutual Releases. The Stipulation shall contain releases substantially conforming to the following terms: 
 (a) Plaintiffs hereby release and forever discharge the Settling Defendants, their respective present and former parents, subsidiaries, divisions and
affiliates, the present and former partners, employees, officers and directors of each of them, the present and former attorneys, accountants, insurers, and agents of each of them, and the predecessors, heirs, successors and assigns of each
(collectively, the “Released Persons”), from any and all claims, demands, rights, liabilities and causes of action of every nature and description whatsoever, whether based in law or equity, on federal, state, local, foreign, statutory or
common law, or any other law, rule, or regulation (including, but not limited to, all claims arising out of or relating to 

  

 4 

 
any acts, omissions, disclosures, public filings, registration statements, financial statements, audit opinions, or statements by the Settling Defendants,
including without limitation, claims for negligence, gross negligence, constructive or actual fraud, negligent misrepresentation, conspiracy, or breach of fiduciary duty), whether known or unknown, whether or not concealed or hidden, accrued or
not accrued, foreseen or unforeseen, matured or not matured, that were asserted or that could have been asserted directly, indirectly, representatively or in any other capacity, at any time, in any forum by Plaintiffs against the Released Persons
arising out of, based upon, or related in any way to: (a) the purchase, acquisition, sale, or disposition of any publicly traded securities of UnitedHealth by any Plaintiff during the Class Period, the allegations that were made or could have
been made in the Consolidated Action and any of the facts, transactions, events, occurrences, disclosures, statements, acts, omissions or failures to act which were or that could have been asserted by Plaintiffs in the Consolidated Action; or
(b) the settlement or resolution of the Consolidated Action (including, without limitation, any claim for attorneys’ fees by Lead Plaintiffs or any Class Member)(the “Released Claims”). Released Claims shall also include any
Unknown Claims. Unknown Claims means any claims that any Plaintiff does not know or suspect to exist in his, her, its or their favor at the time of the release of the Released Persons which, if known by him, her, it, or them might have affected his,
her, its or their settlement with and release of the Released Persons, or might have affected his, her, its, or their decision not to object to this settlement. With respect to any and all Released Claims, the Settling Parties stipulate and agree
that Plaintiffs shall be deemed to have expressly waived the provisions, rights and benefits of California Civil Code §1542, which provides: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH
THE DEBTOR. 
  

 5 

 Plaintiffs shall expressly waive any and all provisions, rights and benefits conferred by any law, or principle of common
law, which is similar, comparable or equivalent to California Civil Code §1542. Any Plaintiff may hereafter discover facts in addition to or different from those that he, she, it or they now know or believe to exist or to be true with respect
to the subject matter of the Released Claims, but the Plaintiffs shall have fully, finally, and forever settled and released any and all Released Claims, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not
concealed or hidden, which now exist, or heretofore have existed, upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct that is negligent, intentional, with or without malice, or
a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional facts. Plaintiffs acknowledge that the foregoing waiver was separately bargained for and a material element of the settlement
of which this release is a part. Notwithstanding the foregoing, nothing in this Memorandum (or in the Stipulation) will release any claims by Plaintiffs against the Non-Settling Defendants. 
 (b) The Settling Defendants on behalf of themselves, their affiliates, predecessors, successors, assigns, agents, employees and all other persons or
entities controlled by, or under common control with, the Settling Defendants shall release and forever discharge Plaintiffs, their respective present and former parents, subsidiaries, divisions and affiliates, the present and former partners,
employees, officers and directors of each of them, the present and former attorneys, accountants, insurers, and agents of each of them, and the predecessors, heirs, successors and assigns of each, from all claims of every nature and description,
known and unknown, relating to the institution, prosecution and/or resolution of the Consolidated Action. While denying liability, the Settling Defendants agree that, based upon publicly available information at the time, the Consolidated Action was
filed in good faith, was not frivolous and is 

  

 6 

 
being settled voluntarily by the Settling Defendants after consultation with competent legal counsel. The Parties agree not to oppose a finding in the
Partial Final Judgment that during the course of the Consolidated Action, the Parties and their respective counsel at all times complied with the requirements of Rule 11 of the Federal Rules of Civil Procedure. 
 7. Non-Settling Defendants. Plaintiffs do not release, and are hereby preserving, any and all of their respective claims and rights against the
Non-Settling Defendants in the Consolidated Action. UnitedHealth affirms that it will continue to advance reasonable defense costs, consistent with Minnesota law, for the Non-Settling Defendants until a judgment is entered as to the Non-Settling
Defendants in the Consolidated Action. Plaintiffs agree that they will not settle any claim or judgment against the Non-Settling Defendants without obtaining from the Non-Settling Defendants the release of any and all claims the Non-Settling
Defendants may have against any of the Released Persons based on, arising out of, relating to, or in connection with the Released Claims or the subject matter thereof, provided that each Settling Defendant shall execute and provide to the
Non-Settling Defendants a release in a form that is satisfactory both to the Settling Defendants and the Non-Settling Defendants. To the extent (but only to the extent) not covered by the Reform Act Bar Order and/or the Complete Bar Order (as
defined below), the Plaintiffs, on behalf of themselves and the Class Members, further agree that in the event Plaintiffs obtain the proceeds of any settlement or judgment against a Non-Settling Defendant (“Non-Settling Defendant
Recovery”), Plaintiffs will reimburse UnitedHealth an amount equal to any settlement or final, non-appealable judgment (up to the amount of the Non-Settling Defendant Recovery) that any Non-Settling Defendant may obtain against any of the
Released Persons based upon the Released Persons’ liability to the Non-Settling Defendants for amounts paid by the Non-Settling Defendants to Plaintiffs, arising out of, relating to, or in connection with the Released Claims or the subject
matter thereof. The sole source of any 

  

 7 

 
reimbursement pursuant to the immediately preceding sentence shall be the amounts collected by Plaintiffs in the Non-Settling Defendant Recovery. In no event
shall Plaintiffs be required to reimburse UnitedHealth for an amount in excess of the Non-Settling Defendant Recovery. In the event a Non-Settling Defendant asserts such a claim against a Released Person related to any claim asserted or judgment
obtained against that Non-Settling Defendant, or settlement entered into by that Non-Settling Defendant, arising from or related to a claim asserted against that Non-Settling Defendant by Plaintiffs, UnitedHealth agrees to pay the reasonable costs
of defending any such claim that may be asserted against any Released Person by any Non-Settling Defendant, and any such Released Person shall defend against such claim in good faith and will not settle such claim without the prior written consent
of Lead Counsel and UnitedHealth, which consent shall not be unreasonably withheld. This provision shall not apply to claims that are independent of the Released Claims. In the event that a settlement is reached between Plaintiffs and a Non-Settling
Defendant (notwithstanding the third sentence of this paragraph), or final judgment is entered in favor of Plaintiffs against a Non-Settling Defendant before the resolution of that Non-Settling Defendant’s potential claims against any Released
Person, any funds collected on account of such settlement or judgment shall not be distributed, but shall be retained by Lead Counsel in an escrow account pending the resolution of any potential claim by the Non-Settling Defendant against such
Released Person(s). 
 8. Bar Orders. The Partial Final Judgment shall contain provisions substantially conforming to the following
paragraphs: 
 (a) In accordance with Section 21D-4(f)(7)(A) of the Private Securities Litigation Reform Act of 1995, 15
U.S.C. § 78u-4(f)(7)(A), each of the Released Persons are discharged from all claims for contribution that have been or may hereafter be brought by or on behalf of any of the Non-Settling Defendants or any of the Settling 

  

 8 

 
Defendants based upon, relating to, or arising out of the Released Claims. Accordingly, (i) the Non-Settling Defendants are permanently barred,
enjoined, and restrained from commencing, prosecuting, or asserting any such claim for contribution against any Released Person based upon, relating to, or arising out of the Released Claims; and (ii) the Released Persons are permanently
barred, enjoined, and restrained from commencing, prosecuting, or asserting any claim for contribution against the Non-Settling Defendants based upon, relating to, or arising out of the Released Claims (“Reform Act Bar Order”). 

(b) The Non-Settling Defendants and the Settling Defendants are permanently barred, enjoined, and restrained from commencing,
prosecuting or asserting any claim, if any, however styled, whether for indemnification, contribution, or otherwise and whether arising under state, federal, or common law, against the Released Persons based upon, arising out of, or relating to the
Released Claims; and the Released Persons are permanently barred, enjoined, and restrained from commencing, prosecuting, or asserting any other claim, if any, however styled, whether for indemnification, contribution, or otherwise and whether
arising under state, federal, or common law, against the Non-Settling Defendants based upon, arising out of, or relating to the Released Claims (the “Complete Bar Order”). 
 (c) If the Partial Final Judgment fails to include the Reform Act Bar Order or the Complete Bar Order (collectively “Bar
Orders”), or if appellate review of the Bar Orders is sought and on such review the Bar Orders are vacated, modified or reversed, then the Settling Defendants shall have the right to terminate the Settlement. 
 (d) Notwithstanding the foregoing provisions, nothing in the Partial Final Judgment will bar the Non-Settling Defendants from pursuing
claims that are independent of the Released Claims against the Released Persons. 
  

 9 

 9. Termination. In the event this Settlement fails to become effective for any reason, the
Settling Parties shall be deemed to have reverted nunc pro tunc to their respective status as of June 30, 2008, and they shall proceed in all respects as if this Memorandum had not been executed and without prejudice in any way from the
negotiation, fact or terms of this Settlement. 
 10. Insurance. Nothing in this Memorandum or Settlement shall affect any rights by
any Settling Defendant under any policies of insurance. 
 11. No Admissions. The Settling Defendants deny any wrongdoing, fault,
liability or damage to Plaintiffs, deny that they engaged in any wrongdoing, deny that they committed any violation of law, and deny that they acted improperly in any way and also assert certain defenses. In view, however, of the uncertainty and
risk of the outcome of any litigation (especially complex securities litigation), the difficulties and substantial expense and length of time necessary to defend the proceeding—including potentially through trial, post-trial motions and
appeals—and to eliminate the burden and expense of further litigation, the Settling Defendants wish to settle the Consolidated Action and put the Released Claims to rest, finally and forever, without in any way acknowledging any
wrongdoing, fault, liability or damage to Plaintiffs. This Memorandum and the terms of the Settlement represent a compromise of disputed claims and the negotiations, discussions, and communications in connection with or leading up to and including
the Settlement are not and shall not be construed as admissions or concessions by the Settling Parties, or any of them, either as to any liability or wrongdoing or as to the merits of any claim or defense. Neither the existence of this Memorandum
nor any of its provisions shall be offered into evidence by any Party or its agents in the Consolidated Action or in any other action, arbitration or proceeding as admissions or concessions of liability or wrongdoing of any nature on the part of the
other Party, or as admissions or concessions concerning the merits of any claim or defense, other than in connection with any action, motion or proceeding to enforce the terms of this Memorandum. 
  

 10 

 12. Benefits of the Settlement to the Class. This Settlement is conditioned upon the approval
thereof by the Boards of both CalPERS and UnitedHealth. Lead Counsel and CalPERS’ General Counsel will recommend to CalPERS’ Board, approval of the Settlement. Provided that the Boards of CalPERS and UnitedHealth approve the Settlement,
(i) CalPERS and Lead Counsel, based upon their thorough evaluation, agree that the Settlement is fair, reasonable and adequate and in the best interests of the Class Members, and that it confers substantial benefits upon the Class Members; and
(ii) CalPERS and Lead Counsel as well as the Settling Defendants and their counsel shall use their best efforts to obtain final Court approval of the Settlement and to encourage all Class Members to participate in the Settlement. 
 13. Derivative Action. CalPERS and Alaska Plumbing agree not to object to the proposed settlement in In re UnitedHealth Group Incorporated
Shareholder Derivative Litigation, No. 06-cv-01216-JMR-FLN (D. Minn.)(the “Derivative Action”), except to the extent the current and publicly known terms of that settlement are modified in a manner that is detrimental to the
interests of the Plaintiffs. Nothing in this paragraph, however, shall prevent Plaintiffs from continuing to enforce, defend or pursue the injunctive relief as to certain property claimed by William W. McGuire, which is subject to the Court’s
Order dated December 26, 2007. Further, nothing in this paragraph shall prevent Plaintiffs from enforcing the terms of, or preserving its rights under this Memorandum. Finally, nothing in this paragraph shall prevent Plaintiffs from pursuing
their claims in the Consolidated Action against William W. McGuire and David J. Lubben (“Reserved Claims”), or from objecting to any attempt by the plaintiffs in the Derivative Action or any of the Settling Defendants to release any
Reserved Claim in the Derivative Action. 
  

 11 

 14. Stay of Proceedings. The Settling Parties agree to seek an order from the Court staying all
proceedings in the Consolidated Action for thirty (30) days. Plaintiffs further agree that pending the entry of the Partial Final Judgment, they will (i) not seek to reopen discovery as against the Settling Defendants; (ii) not seek
the production of or challenge any privilege with respect to interview memoranda prepared by Wilmer Cutler Pickering Hale and Dorr LLP, documents reflecting attorneys’ mental impressions of the interviews, the memorandum prepared by
Covington & Burling LLP, and the two memoranda prepared by Dorsey & Whitney LLP; and (iii) not make any further effort to seek public disclosure of any discovery materials that have been previously designated Confidential or
Highly Confidential (except as may be required at trial). The Settling Parties will also request that the Court take no further action with regard to any pending motions or objections filed by the Settling Parties. Nothing in this paragraph will
prevent Plaintiffs from (i) pursuing any motion practice between Plaintiffs and the Non-Settling Defendants; (ii) seeking any discovery from the Non-Settling Defendants or (iii) taking the Rule 30(b)(6) metadata deposition,
provided that such motion practice or discovery does not involve or result in any of the activities described in the second sentence of this paragraph. 
 15. Stipulation. Promptly after execution of this Memorandum, the Settling Parties shall negotiate in good faith and agree upon the Stipulation. 
 16. Preliminary Approval. The Settling Parties shall use their best efforts to present the Settlement to Hon. James M. Rosenbaum, U.S. District
Judge, subject to the Court’s availability, for preliminary approval as soon as practicable. 
 17. Confidentiality of
Settlement. The Settling Parties and their counsel shall keep the Settlement, and the prospect of settlement, absolutely confidential until all Settling Parties have executed this Memorandum (except for such disclosure that may be required to
the 

  

 12 

 
Court or as required by law, including under the California Public Records Act). UnitedHealth and Plaintiffs will exchange drafts of press releases
concerning the Settlement by 7:00 p.m., Eastern Daylight Time, in advance of the day that UnitedHealth intends to publicly announce the Settlement. 
 18. Counterparts. This Memorandum may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The counsel below warrant that they
have the full authority to execute this Memorandum on behalf of the Settling Parties. 
 19. Cooperation. UnitedHealth agrees to
cooperate in the authentication of documents through the production of a witness at trial or otherwise. 
 20. Other Cases. This
Settlement is not conditioned upon settlement or approval of settlement of any derivative suits or ERISA suits. The release in this Consolidated Action will expressly state it is not releasing any derivative or ERISA claims. 
 21. Arm’s-Length Agreement. The Settling Parties have engaged in substantial arm’s length negotiations in an effort to
resolve the Consolidated Action, including conducting numerous meetings and telephone conferences where the terms of the agreements detailed herein were extensively debated and negotiated, at times with the assistance of mediators. 
 22. Performance. The Settling Parties acknowledge that the failure to complete the Settlement under the terms of this Memorandum
will result in irreparable harm that cannot be adequately compensated through money damages and that each therefore agrees that specific performance is the appropriate remedy for breach of this Memorandum, provided, however, that only the Plaintiffs
and UnitedHealth may seek relief under this section. 
  

 13 

							
	Dated: July 1, 2008	 		 	COUGHLIN STOIA GELLER RUDMAN & ROBBINS LLP (on behalf of Plaintiffs California Public Employees’ Retirement System and Alaska Plumbing and Pipefitting Industry Pension
Trust and the Class Members)
				
		 		 	By:	 	 /s/ Michael J. Dowd

		 		 		 	Darren J. Robbins
		 		 		 	Michael J. Dowd
		 		 		 	Lead Counsel
			
		 		 	O’MELVENY & MYERS LLP (on behalf of Defendants UnitedHealth Group Inc., Stephen J. Hemsley, Patrick J. Erlandson, Robert J. Sheehy, William A. Munsell, Tracy L. Bahl,
Lois E. Quam, James A. Johnson, Thomas H. Kean, Mary O. Mundinger, William C. Ballard, Douglas W. Leatherdale, William G. Spears, Gail R. Wilensky, Richard T. Burke, Donna E. Shalala, and Robert L. Ryan)
				
		 		 	By:	 	 /s/ Charles E. Bachman

		 		 		 	Charles E. Bachman

  

 14Transitional Compensation Agreement

 EXHIBIT 10.1 
 AMENDED AND RESTATED 
 TRANSITIONAL COMPENSATION AGREEMENT 
 AGREEMENT by and between AMCORE Financial, Inc., a Nevada corporation (the “Company”),
and Guy Francesconi (the “Executive”), dated as of the 25th day of August 2008. This
Agreement amends, restates and supersedes any and all prior agreements between the Company and the Executive relating to the subject matter of this Agreement, including (but not by way of limitation) the Transitional Compensation Agreement dated
April 30, 2007. 
 The Board of Directors of the Company (the “Board”) has determined that it is in the best interests
of the Company and its shareholders to assure that the Company will have the continued dedication of the Executive, notwithstanding the possibility, threat or occurrence of a Change of Control (as defined below) of the Company. The Board believes it
is imperative to diminish the inevitable distraction of the Executive by virtue of the personal uncertainties and risks created by a pending or threatened Change of Control, to encourage the Executive’s full attention and dedication to the
Company currently and in the event of any threatened or pending Change of Control, and to provide the Executive with compensation and benefit arrangements upon a Change of Control which ensure that the compensation and benefits expectations of the
Executive will be satisfied and which are competitive with those of other similar corporations. 
 Therefore, in order to accomplish these
objectives, the Board has caused the Company to enter into this Agreement. 
 As a condition to the effectiveness of this Agreement, the
Executive has executed the Confidentiality and Non-Competition Agreement attached hereto as Exhibit A. 
 NOW, THEREFORE, IT IS HEREBY AGREED
AS FOLLOWS: 
 1. Certain Definitions. 
 (a) The “Effective Date” shall mean the first date during the Change of Control Period (as defined in paragraph (b), below) on which a Change of Control (as defined in Section 2) occurs. Anything in
this Agreement to the contrary notwithstanding, if a Change of Control occurs and if the Executive’s employment with the Company is terminated or the Executive ceases to be an officer of the Company prior to the date on which the Change of
Control occurs, and if it is reasonably demonstrated by the Executive that such termination of employment or cessation of status as an officer (i) was at the request of a third party who has taken steps reasonably calculated to effect the
Change of Control, or (ii) otherwise arose in connection with or anticipation of the Change of Control and was not (A) for conduct by the Executive of the type described in Section 4(b), below, (B) for significant deficiencies in
the Executive’s performance of his duties to the Company (including, but not by way of limitation, significant failure to cooperate in implementing a decision of the Board), or (C) for some other specific substantial business reason
unrelated to the Change of Control, then for all purposes of this Agreement the “Effective Date” shall mean the date immediately prior to the date of such termination of employment or cessation of status as an officer. 
 (b) The “Change of Control Period” shall mean the period which commenced on April 30, 2007, and ending on the third
anniversary of such date; provided, however, that on April 30, 2008, and on each annual anniversary of such date (such date and each annual anniversary thereof being hereinafter referred to as a “Renewal Date”), this Agreement
and the Change of Control Period shall be automatically extended so as to terminate three (3) years from such Renewal Date, unless at least sixty (60) days prior to the Renewal Date the Company shall give notice to the Executive that the
Change of Control Period shall not be so extended, in which case this Agreement shall terminate upon the expiration of the Change of Control Period or, if an Effective Period (as defined in Section 3) is then in effect, upon the expiration of
the Effective Period. 
 2. Change of Control. For the purpose of this Agreement, a “Change of Control” shall mean the
occurrence, after the date hereof, of any of the following events: 
 (a) The acquisition, other than from the Company, by any
individual, entity or group (within the meaning of Section 13(d)(3) or l4(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of Company securities immediately after which such person is the beneficial owner
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifteen percent (15%) or more of either the then outstanding shares of common stock of the Company or the combined 

 
voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors, but excluding for this purpose
any such acquisition by the Company or any of its subsidiaries, or any employee benefit plan (or related trust) of the Company or its subsidiaries, or any corporation with respect to which, following such acquisition, more than sixty percent
(60%) of, respectively, the then outstanding shares of common stock of such corporation and the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors is then
beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the common stock and voting securities of the Company immediately prior to such acquisition in
substantially the same proportion as their ownership, immediately prior to such acquisition, of the then outstanding shares of common stock of the Company or the combined voting power of the then outstanding voting securities of the Company entitled
to vote generally in the election of directors, as the case may be; or 
 (b) Individuals who, as of the date hereof,
constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided that any individual becoming a director subsequent to the date hereof, whose election, or nomination for election by
the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose,
any such individual whose initial assumption of office is in connection with an actual or threatened election contest, including, but not limited to, a consent solicitation, relating to the election of the directors of the Company (as such terms are
used in Rule 14a-11 of Regulation l4A promulgated under the Exchange Act); or 
 (c) There occurs (i) a reorganization,
merger or consolidation of the Company or any direct or indirect subsidiary of the Company, in each case, with respect to which all or substantially all of the individuals and entities who were the respective beneficial owners of the common stock
and voting securities of the Company immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or consolidation, beneficially own, directly or indirectly, more than sixty percent (60%) of,
respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the ultimate parent corporation of any
corporation resulting from such reorganization, merger or consolidation, or (ii) shareholder approval of a complete liquidation or dissolution of the Company, or (iii) the sale or other disposition of all or substantially all of the assets
of the Company. 
 3. Effective Period. The Effective Period shall be in effect for the period commencing on the Effective Date and
ending on the second anniversary of such date (the “Effective Period”). 
 4. Termination of Employment. 
 (a) Death or Disability. The Executive’s employment shall terminate automatically upon the Executive’s death during the
Effective Period. If the Company determines in good faith that the Disability of the Executive has occurred during the Effective Period (pursuant to the definition of Disability as set forth below), it may give to the Executive written notice in
accordance with Section 11(b) of this Agreement of its intention to terminate the Executive’s employment. In such event, the Executive’s employment with the Company shall terminate effective on the thirtieth (30th) day after
receipt of such notice by the Executive (the “Disability Effective Date”), provided that, within the thirty (30) days after such receipt, the Executive shall not have returned to full-time performance of the Executive’s duties.
For purposes of this Agreement, “Disability” shall mean the absence of the Executive from the Executive’s duties with the Company on a full-time basis for one hundred and eighty (180) consecutive business days as a result of
incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to the Executive or the Executive’s legal representative (such agreement as to
acceptability not to be withheld unreasonably). 
 (b) Cause. 
 (i) The Company may terminate the Executive’s employment during the Effective Period for Cause and may suspend the Executive from his
duties with full pay and benefits if the Executive is indicted for a felony involving moral turpitude; provided, however, that the Executive will repay all amounts paid by the Company from the date of such suspension if the Executive is convicted of
such felony. For purposes of this Agreement, “Cause” shall mean (A) the willful and continued failure by the Executive to substantially perform the Executive’s duties with the Company (other than any such failure resulting from
the Executive’s incapacity due to physical or mental illness or any such actual or anticipated failure after the issuance of a Notice of Termination for Good Reason by the Executive pursuant to Section 4(d) hereof) after a written demand
for substantial performance is delivered to the Executive by the Board, which demand specifically identifies the manner in which the Board believes that the Executive has not substantially performed the Executive’s duties, or (B) the
willful engaging by the Executive in conduct which is demonstrably and materially injurious to the Company or its 

  

 2 

 
subsidiaries, monetarily or otherwise. For purposes of clauses (A) and (B) of this definition, (x) no act, or failure to act, on the
Executive’s part shall be deemed “willful” unless done, or omitted to be done, by the Executive not in good faith and without reasonable belief that the Executive’s act, or failure to act, was in the best interest of the Company
and (y) in the event of a dispute concerning the application of this provision, no claim by the Company that Cause exists shall be given effect unless the Company establishes to the Board by clear and convincing evidence that Cause exists, and
the Board adopts a finding to that effect. 
 (ii) A Notice of Termination for Cause must include a copy of a resolution duly
adopted by the affirmative vote of not less than three-quarters (3/4) of the entire membership of the Board at a meeting of the Board which was called and held for the purpose of considering such termination (after reasonable notice to the
Executive and an opportunity for the Executive, together with the Executive’s counsel, to be heard before the Board) finding that, in the good faith opinion of the Board, the Executive was guilty of conduct set forth in clause (A) or
(B) of the definition of Cause herein, and specifying the particulars thereof in detail. 
 (c) Good Reason. The
Executive’s employment may be terminated during the Effective Period by the Executive for Good Reason. For purposes of this Agreement, “Good Reason” shall mean: 
 (i) The assignment to the Executive of any duties inconsistent in any material respect with the Executive’s position (including
status, offices, titles and reporting requirements), authority, duties or responsibilities as in effect immediately prior to the Effective Date, or any other action by the Company which results in a diminution in such position, authority, duties or
responsibilities, including, without limitation, if the Executive was, immediately prior to the Effective Date, an executive officer of a public company, the Executive ceasing to be an executive officer of a public company, but excluding for this
purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company within thirty (30) days after receipt of notice thereof given by the Executive; 
 (ii) Any reduction by the Company in Executive’s compensation or benefits as in effect immediately prior to the Effective Date, other
than an isolated, insubstantial and inadvertent reduction not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive; 
 (iii) The Company’s requiring the Executive to be based at any office or location more than twenty (20) miles from that in
effect immediately prior to the Effective Date; 
 (iv) Any purported termination by the Company of the Executive’s
employment otherwise than as expressly permitted by this Agreement; or 
 (v) Any failure by the Company to comply with and
satisfy Section 10(c) of this Agreement, provided that such successor has received at least ten (10) days’ prior written notice from the Company or the Executive of the requirements of Section 10(c) of this Agreement. 

For purposes of this Section 4(c), any good faith determination of “Good Reason” made by the Executive shall be conclusive. 
 (d) Notice of Termination. Any termination by the Company for Cause, or by the Executive for Good Reason, shall be communicated by
a Notice of Termination to the other party given in accordance with Section 11(b) of this Agreement. For purposes of this Agreement, a “Notice of Termination” means a written notice which (i) indicates the specific termination
provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated
and (iii), if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date (which date shall be not more than fifteen (15) days after the giving of such notice). The failure by the
Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company hereunder or preclude the Executive or the
Company from asserting such fact or circumstance in enforcing the Executive’s or the Company’s rights hereunder. 
  

 3 

 (e) Date of Termination. “Date of Termination” means (i), if the
Executive’s employment is terminated by the Company for Cause, or by the Executive for Good Reason, the date of receipt of the Notice of Termination or any later date specified therein, as the case may be, (ii), if the Executive’s
employment is terminated by the Company other than for Cause or Disability or by the Executive other than for good reason, the Date of Termination shall be the date on which the terminating party notifies the other party of such termination, and
(iii), if the Executive’s employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of the Executive or the Disability Effective Date, as the case may be. 
 (f) Separation From Service. “Separation From Service” means a termination of employment that meets the “separation
from service” requirements under section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and section 1.409A-1(h) of the regulations thereunder (as may be amended from time to time and including any successor
thereto). 
 5. Obligations of the Company upon Termination. 
 (a) By Company Other Than for Cause or Disability or By Executive for Good Reason. If, during the Effective Period, the Company
shall terminate the Executive’s employment other than for Cause or Disability, or the Executive shall terminate employment for Good Reason: 
 (i) The Company shall pay to the Executive in a lump sum the following amounts, payment to be made at the times described below: 
 (A) The sum of 
 (1) the Executive’s then-current annual base salary through the Date of Termination to the extent not theretofore paid, which amount shall be paid in cash within 30 days after the Date of Termination; 
 (2) the product of (x) Executive’s Recent Average Bonus (as defined below) and (y) a fraction, the numerator of which is
the number of days in the then current fiscal year through the Date of Termination, and the denominator of which is three hundred and sixty-five (365). This amount shall be paid during the 30-day period commencing six months subsequent to
Executive’s Separation From Service, and, in order to compensate for the delay, the amounts to be paid shall be increased by six-months interest, computed at the prime rate as reported in the Wall Street Journal on the nearest date preceding
the Separation From Service (the “Prime Rate”); 
 (3) any compensation previously deferred by the Executive
(together with any accrued interest or earnings thereon and as adjusted to reflect any other appreciation or depreciation in value). This amount shall be paid in cash within 30 days after the Separation From Service; provided that, the payment
described in this section 5(a)(i)(A)(3) shall only be paid as an immediate lump sum if (x) a lump sum payment had been previously elected by the Executive in accordance with section 409A or (y) the Separation From Service is within two
years following the Change in Control and the Change in Control would also qualify as a Change in Control under section 409A and the regulations thereunder; and 
 (4) any accrued vacation pay; the extent not theretofore paid, which amount shall be paid in cash within 30 days after the Date of
Termination (the sum of the amounts described in parts (1), (2), (3) and (4), above, being hereinafter referred to as the “Accrued Obligations”). 
 For purposes of this Agreement, Executive’s Recent Average Bonus shall be the average annualized (for any fiscal year consisting of less than 12 full months or with respect to which the Executive has been
employed by the Company for less than 12 full months) bonus paid or payable, before taking into account any deferral, to the Executive by the Company and its affiliated companies in respect of the three fiscal years immediately preceding the fiscal
year in which the termination of the Executive’s employment occurs; provided, however, that (i) if the Executive was not employed by the Company for any full fiscal year that would otherwise be included in the calculate on of Recent
Average Bonus, that year will be excluded from the calculation of Recent Average Bonus; and (ii) if the Executive was not employed by the Company for at least one full fiscal year during the period that would otherwise be included in the
calculation of Recent Average Bonus, the Executive’s Recent Average Bonus will instead be calculated as the Executive’s Target Bonus for the year in which the termination occurred; and 
  

 4 

 (B) The amount (such amount being hereinafter referred to as the “Severance
Amount”) equal to (i) the product of 2.00 multiplied by the Executive’s then-current annual base salary, plus (ii) the product of 2.00 multiplied by the Executive’s Recent Average Bonus; provided, however, that the aggregate
of such amounts shall be reduced by the present value (determined as provided in Section 280G(d)(4) the “Code”) of any other amount of severance relating to salary or bonus continuation to be received by the Executive, upon such
termination of employment, under any other severance plan, policy or arrangement of the Company. One-half of the Severance Amount (also referred to as the “Non-Compete Payment”) shall be deemed to be allocable to the performance of the
covenants applicable to Executive pursuant to the Confidentiality and Non-Competition Agreement attached hereto as Exhibit A. This amount shall be paid during the 30-day period commencing six months subsequent to Executive’s Separation From
Service, and, in order to compensate for the delay, the amounts to be paid shall be increased by six-months interest at the Prime Rate; and 
 (ii) At the Date of Termination, stock options, restricted stock, and other awards relating to stock under equity incentive plans or programs of the Company and its affiliates which would have become vested
(non-forfeitable) if Executive’s employment had continued for thirty-six (36) months thereafter, excluding awards that require performance goals to be achieved in addition to passage of time and continued employment, will be immediately
vested and exercisable, and any such stock options and other outstanding stock options already vested at or before the Date of Termination shall remain outstanding and exercisable for a period that is the greater of one year after the Date of
Termination (but in no event after the stated expiration date of such option) or such longer period as may be provided under the applicable plan or program, and any such awards subject to settlement at a date later than the vesting date shall be
immediately settled; provided, however, that rights set forth in this paragraph 5(a)(ii) shall be subject to the limitations described in Section 6; and 
 (iii) The Company shall pay to the Executive a lump sum equal to X, which amount shall be paid during the 30-day period commencing six
months subsequent to Executive’s Separation From Service. For the purpose of the preceding sentence, X equals the value of the benefits that would have been provided to Executive and/or the Executive’s family during the 24 month period
immediately following the Date of Termination, if the Executive’s employment had not been terminated, in accordance with (A) the welfare benefit plans, practices, programs or policies of the Company and its affiliated companies as in
effect and applicable generally to other peer executives and their families or, if more favorable, applicable to the Executive and his family during the ninety (90)-day period immediately preceding the Effective Date or (B) if more favorable to
the Executive, those in effect generally from time to time thereafter with respect to other peer executives of the Company and its affiliated companies and their families For the purpose of computing X with respect to benefits where the Company pays
insurance premiums, the cost of benefits shall equal the insurance premiums that would have been paid over such 24 month period that provides benefits to the Executive, based on the insurance premiums in effect on the Date of Termination. For
purposes of determining eligibility of the Executive for retiree benefits pursuant to such plans, practices, programs and policies, the Executive shall be considered to have remained employed during the 24 month period immediately following the Date
of Termination and to have retired on the last day of such period (and, to the extent Executive is eligible to receive retiree benefits that duplicate the benefits that would otherwise be taken into account in computing X, X shall be reduced); and

 (iv) The Company shall pay to the Executive a lump sum equal to Y, which amount shall be paid during the 30-day period
commencing six months subsequent to Executive’s Separation From Service. For the purpose of the preceding sentence, Y equals the value of the benefits that would have been provided to Executive during the 24 month period immediately following
the Date of Termination (if the Company had continued to provide the Executive and his family with the benefits and perquisites at least equal to those which would have been provided to them if the Executive’s employment had not been
terminated, in accordance with the terms generally applicable with respect to the provision of such benefits and perquisites during the ninety (90) day period immediately preceding the Effective Date, or, if more favorable to the Executive, in
effect generally from time to time thereafter during such 24 month period with respect to other peer executives of the Company and its affiliated companies and their families. These Benefits shall include (but shall not be limited to) the following:
employer contributions to the AMCORE Financial Security Plan, employer contributions to the AMCORE Deferred Compensation Plan, AMCORE Cash Profit Plan or any other defined contribution retirement plan, club membership fees, financial planning
allowance and car allowance. In computing Y, the Company shall determine the amount of a benefit annually provided by the Company by (A) assuming that the Executive’s base pay would have remained in effect at the rate in effect on the Date
of Termination and the Executive would have received annual bonuses equal to the Recent Average Bonus, and (B) assuming, in the case of club membership fees, financial planning allowance, car allowance, and similar benefits, that the Executive
would receive such benefits during the twelve months following the Date of Termination at the same rate that he received such benefits during the 24 months ending on the last day of the calendar quarter preceding the Date of Termination. 

(v) all amounts payable to the Executive pursuant to this Section 5 are subject to the limitations described in Section 6 of
this Agreement. 
  

 5 

 (b) Death. If the Executive’s employment is terminated by reason of the
Executive’s death during the Effective Period, this Agreement shall terminate without further obligations to the Executive’s legal representatives under this Agreement, other than for (i) payment of the Accrued Obligations (which
payments shall, notwithstanding the language of 5(a)(i)(A) above, be paid to the Executive’s estate or beneficiary, as applicable, in a lump sum in cash within thirty (30) days of the Date of Termination, and shall not include the interest
factor described in 5(a)(i)(A) above) and (ii) the payment of the benefits described in section 5(a)(iii) and (iv) (which payments shall, notwithstanding the language of 5(a)(iii) and (iv) above, be paid to the Executive’s estate
or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination). 
 (c) Disability. If
the Executive’s employment is terminated by reason of the Executive’s Disability during the Effective Period, this Agreement shall terminate without further obligations to the Executive, other than for (i) payment of the Accrued
Obligations and (ii) the timely payment of the benefits described in section 5(a)(iii) and (iv), but for this purpose only computing the amount of such benefits that would have been payable during the 24 month period immediately following the
Date of Termination. Notwithstanding the language of section 5(a)(i)(A), (iii), and (iv), to the extent permitted under Section 409A, the payment of the obligations described in this subsection (c) shall be paid within 30 days of the Date
of Termination (and the interest factor described in section 5(a)(i)(A) shall not apply) if the Disability constitutes a disability within the meaning of section 409A of the Code and the regulations thereunder. 
 (d) Cause; Other than for Good Reason. If, during the Effective Period, the Executive’s employment shall be terminated by the
Company for Cause or the Executive terminates employment not for Good Reason: 
 (i) The Company may elect to have the
Confidentiality and Non-Competition Agreement attached hereto as Exhibit A become effective and remain in effect in accordance with the terms of that Agreement, by giving notice of such election to the Executive, not later than five
(5) business days after the effectiveness of the Executive’s termination of employment. 
 (ii) If the
Executive’s employment was terminated by the Company for Cause, the Company shall pay the Executive’s then current annual base salary through the Date of Termination, plus the amount of any compensation previously deferred by the Executive
(together with any accrued interest or earnings thereon and as adjusted to reflect any other appreciation or depreciation in value) and any accrued vacation pay; in each case to the extent theretofore unpaid; provided that the payment of previously
deferred compensation, as adjusted, shall only be paid as an immediate lump sum if (x) a lump sum payment had been previously elected by the Executive or (y) the Separation From Service is within two years following the Change in Control
and the Change in Control would also qualify as a Change in Control under section 409A and the regulations thereunder. 
 (iii) If the Executive terminates his employment other than for Good Reason, the Company shall pay to the Executive the Accrued Obligations. In such case, all Accrued Obligations shall be paid to the Executive in a lump sum at the times set
forth in section 5(a)(i)(A) above. 
 (iv) Upon payment by the Company of the applicable amounts under this Section 5(d),
the Agreement shall terminate without further obligations to the Executive. 
 6. Certain Additional Payments by the Company. The
Company agrees that: 
 (a) Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined
that any payment or distribution by the Company to or for the benefit of the Executive (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional
payments required under this Section 6) (a “Payment”) would be subject to the excise tax imposed by Section 4999 of the Code or if any interest or penalties are incurred by the Executive with respect to such excise tax (such
excise tax, together with any such interest and penalties, being hereinafter collectively referred to as the “Excise Tax”), then the Executive shall be entitled to receive an additional payment (a “Gross-Up Payment”) in an amount
such that, after payment by the Executive of all taxes (including any interest or penalties imposed with respect to such taxes), including, without limitation, any income and employment taxes (and any interest and penalties imposed with respect
thereto) and Excise Tax imposed upon the Gross-Up Payment, and, after taking into account the phase out of the itemized deductions and personal exemptions attributable to the Gross-Up Payment, the Executive retains an amount of the Gross-Up Payment
equal to the Excise Tax imposed upon the Payment. 
  

 6 

 (b) Subject to the provisions of paragraph (c), below, all determinations required to be
made under this Section 6, including whether and when a Gross-Up Payment is required and the amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such determination, shall be made by Deloitte & Touche LLP
(or another accounting firm designated by the Company) (the “Accounting Firm”), which shall provide detailed supporting calculations both to the Company and the Executive within fifteen (15) business days of the receipt of notice from
the Executive that there has been a Payment, or such earlier time as is requested by the Company. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity or group affecting the Change of Control, the
Executive shall appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm
shall be borne solely by the Company. Any Gross-Up Payment, as determined pursuant to this Section 6, shall be paid by the Company to the Executive within five (5) days of the receipt of the Accounting Firm’s determination. If the
Accounting Firm determines that no Excise Tax is payable by the Executive, it shall furnish the Executive with a written opinion that failure to report the Excise Tax on the Executive’s applicable federal income tax return would not result in
the imposition of a negligence or similar penalty. Any good faith determination by the Accounting Firm shall be binding upon the Company and the Executive. As a result of the uncertainty in the application of Section 4999 of the Code at the
time of the initial determination by the Accounting Firm hereunder, it is possible that Gross-Up Payments which will not have been made by the Company should have been made (“Underpayment”), consistent with the calculations required to be
made hereunder. In the event that the Company exhausts its remedies pursuant to paragraph (c), below, and the Executive thereafter is required to make a payment of any Excise Tax, the Accounting Firm shall determine the amount of the Underpayment
that has occurred and any such Underpayment shall be promptly paid by the Company to or for the benefit of the Executive. 
 (c) The Executive shall notify the Company in writing of any claim by the Internal Revenue Service that, if successful, would require the payment by the Company of a Gross-Up Payment. Such notification shall be given as soon as practicable
but no later than fifteen (15) business days after the Executive is informed in writing of such claim and shall apprise the Company of the nature of such claim and the date on which such claim is requested to be paid. The Executive shall not
pay such claim prior to the expiration of the thirty (30)-day period following the date on which Executive gives such notice to the Company (or such shorter period ending on the date that any payment of taxes with respect to such claim is due). If
the Company notifies the Executive in writing prior to the expiration of such period that it desires to contest such claim, the Executive shall: 
 (i) Give the Company any information reasonably requested by the Company relating to such claim, 
 (ii) Take such action in connection with contesting such claim as the Company shall reasonably request in writing from time to time, including, without limitation, accepting legal representation with respect to such claim by an attorney
reasonably selected by the Company, 
 (iii) Cooperate with the Company in good faith in order effectively to contest such
claim, and 
 (iv) Permit the Company to participate in any proceedings relating to such claim; provided, however, that the
Company shall bear and pay directly all costs and expenses (including additional interest and penalties) incurred in connection with such contest and shall indemnify and hold the Executive harmless, on an after-tax basis, for any Excise Tax or
income tax (including interest and penalties with respect thereto) imposed as a result of such representation and payment of costs and expenses. Without limiting the foregoing provisions of this paragraph (c), the Company shall control all
proceedings taken in connection with such contest and, at its sole option, may pursue or forego any and all administrative appeals, proceedings, hearings and conferences with the taxing authority in respect of such claim and may, at its sole option,
either direct the Executive to pay the tax claimed and sue for a refund or contest the claim in any permissible manner; and the Executive agrees to prosecute such contest to a determination before any administrative tribunal, in a court of initial
jurisdiction and in one or more appellate courts, as the Company shall determine; provided, however, that if the Company directs the Executive to pay such claim and sue for a refund, the Company shall advance the amount of such payment to the
Executive on an interest-free basis and shall indemnify and hold the Executive harmless, on an after-tax basis, from any Excise Tax or income tax (including interest or penalties with respect thereto) imposed with respect to such advance or with
respect to any imputed income with respect to such advance; and further provided that any extension of the statute of limitations relating to payment of taxes for the taxable year of the Executive with respect to which such contested amount is
claimed to be due is limited solely to such contested amount. Furthermore, the Company’s control of the contest shall be limited to issues with respect to which a Gross-Up Payment would be payable hereunder and the Executive shall be entitled
to settle or contest, as the case may be, any other issue raised by the Internal Revenue Service or any other taxing authority. 
  

 7 

 (d) If, after the receipt by the Executive of an amount advanced by the Company pursuant
to paragraph (c), above, the Executive becomes entitled to receive any refund with respect to such claim, the Executive shall (subject to the Company’s complying with the requirements of said paragraph (c)) promptly pay to the Company the
amount of such refund (together with any interest paid or credited thereon, after taxes applicable thereto). If, after the receipt by the Executive of an amount advanced by the Company pursuant to said paragraph (c), a determination is made that the
Executive shall not be entitled to any refund with respect to such claim and the Company does not notify the Executive in writing of its intent to contest such denial of refund prior to the expiration of thirty (30) days after such
determination, then such advance shall be forgiven and shall not be required to be repaid and the amount of such advance shall offset, to the extent thereof, the amount of the Gross-Up Payment required to be paid. 
 In order to comply with section 409A, all payments due under this section shall (i) not be made earlier than six months following the
Executive’s Separation From Service and (ii), if otherwise due, shall be made no later than the last date for payment provided by Treasury Regulations section 1.409A 3(i)(iv), or successor regulations. 
 7. Non-exclusivity of Rights. Except as explicitly provided in this Agreement, nothing in this Agreement shall prevent or limit the
Executive’s continuing or future participation in any plan, program, policy or practice provided by the Company or any of its affiliated companies and for which the Executive may qualify, nor shall anything herein limit or otherwise affect such
rights as the Executive may have under applicable law or under any other contract or agreement with the Company or any of its affiliated companies. Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any
other plan, policy, practice or program of; or any other contract or agreement with, the Company or any of its affiliated companies at, or subsequent to, the Date of Termination shall be payable in accordance with such plan, policy, practice or
program or contract or agreement except as explicitly modified by this Agreement 
 8. Full Settlement; Resolution of Disputes.

 (a) The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its
obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others (except as specifically provided with respect to the Non-Compete
Payment). In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and, except as provided in
Section 5(a)(iii) of this Agreement, such amounts shall not be reduced whether or not the Executive obtains other employment. The Company agrees to pay promptly upon receipt of proper invoices, to the fullest extent permitted by law, all legal
fees and expenses which the Executive may reasonably incur as a result of any contest by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance
thereof (including as a result of any contest initiated by the Executive about the amount of any payment due pursuant to this Agreement), plus in each case interest on any delayed payment at the applicable federal rate provided for in
Section 7872(f)(2)(A) of the Code; provided, however, that in the event that it is finally judicially determined that the Executive was terminated for Cause, then the Executive shall be obligated to repay to the Company the full amount of all
such legal fees and expenses paid for the Executive by the Company in connection with that contest, plus interest at the rate described above. 
 (b) If there shall be any dispute between the Company and the Executive (i) in the event of any termination of the Executive’s employment by the Company, whether such termination was for Cause, or
(ii) in the event of any termination of employment by the Executive, whether Good Reason existed, then, unless and until there is a final, nonappealable judgment by a court of competent jurisdiction declaring that such termination was for Cause
or that the determination by the Executive of the existence of Good Reason was not made in good faith, the Company shall pay all amounts, and provide all benefits, to the Executive and/or the Executive’s family or other beneficiaries, as the
case may be, that the Company would be required to pay or provide pursuant to Section 5(a) hereof as though such termination were by the Company without Cause or by the Executive with Good Reason; provided, however, that the Company shall not
be required to pay any disputed amounts pursuant to this paragraph except upon receipt of an undertaking by or on behalf of the Executive and/or the other recipient(s), as the case may be, to repay all such amounts to which the Executive or other
recipient, as the case may be, is ultimately adjudged by such court not to be entitled. 
 9. Confidential Information. The Executive
shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its affiliated companies, and their respective businesses, which shall have been obtained
by the Executive during the Executive’s employment by the Company or any of its affiliated companies and which shall not be or become public knowledge (other than by acts by the Executive or representatives of the Executive in violation of this
Agreement). After termination of the Executive’s employment with the Company, the Executive shall not, without the prior written consent of the Company or as may otherwise be required by law or legal process, communicate or divulge any such
information, knowledge or data to anyone other than the Company and those designated by it. However, in no event shall an asserted violation of the provisions of this Section 9 constitute a basis for deferring or withholding any amounts
otherwise payable to the Executive under this Agreement. 
  

 8 

 10. Successors. 
 (a) This Agreement is personal to the Executive and, without the prior written consent of the Company, no obligations or rights hereunder
shall be assignable by the Executive otherwise than by will or the laws of descent or distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal representatives. 
 (b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. 
 (c) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement, by operation of law or otherwise.

 11. Miscellaneous. 
 (a) This Agreement shall be governed by and construed in accordance with the laws of the State of Illinois, without reference to principles of choice of law. The captions of this Agreement are for convenience only and
are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.

 (b) All notices and other communications hereunder shall be in writing and shall be given to the other party by hand
delivery or commercial messenger delivery or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 If to the Executive: 
 Guy Francesconi 
 [employee address] 
 If to the Company: 
 AMCORE Financial, Inc. 
 501 Seventh Street

 P.O. Box 1537 
 Rockford,
Illinois 61110-0037 
 Attention: Ms. Lori M. Burke 
 or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee. 
 (c) The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement. 
 (d) The Company may withhold from any amounts payable under this Agreement such federal, state
or local taxes as shall be required to be withheld pursuant to any applicable law or regulation. 
 (e) The Executive’s
or the Company’s failure to insist upon strict compliance with any provision hereof or the failure to assert any right that the Executive or the Company may have hereunder, including, without limitation, the right of the Executive to terminate
employment for Good Reason pursuant to Section 4(c) of this Agreement, shall not be deemed to be a waiver of such provision or right or of any other provision of or right under this Agreement. 
 (f) The Executive and the Company acknowledge that this Agreement is not a contract of employment and that, except as may otherwise be
provided under any other written agreement between the Executive and the Company, the employment of the Executive by the Company is, and shall remain during the Effective Period, “at will” and may, subject to Section 5, above, be
terminated by either the Executive or the Company at any time. Moreover, subject to Section 1, above, if prior to the Effective Date (i) the Executive’s employment with the Company and all affiliates terminates or (ii) the
Executive ceases to be an officer of the Company and of all affiliates, then the Executive shall have no further rights under this Agreement. 
  

 9 

 (g) This Agreement embodies the entire agreement and understanding between the Company
and the Executive and supersedes all prior agreements and understandings between the Company and Executive relating to the subject matter hereof. 
 (h) The provisions of this Agreement are intended to comply with section 409A as it applies to an individual who is a “specified employee” as defined in section 409A. To the extent any provision is
inconsistent with section 409A, it shall be deemed modified so that the modified provision is consistent with section 409A. 
 IN WITNESS
WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the authorization of its Board of Directors, the Company has caused these presents to be executed in its name on its behalf, all as of the day and year first above
written. 
  

			
	AMCORE FINANCIAL, INC.
		
	By:	 	 
		 	Lori M. Burke
	Its	 	SVP Administrative Services
		
	By:	 	 
		 	Guy Francesconi (“Executive”)

  

 10 

 AMENDED AND RESTATED 
 EXHIBIT A 
 CONFIDENTIALITY AND NON-COMPETITION AGREEMENT 
 CONFIDENTIALITY AND NON-COMPETITION AGREEMENT, dated as of August 25, 2008, by and between AMCORE Financial, Inc. (the “Company”)
and Guy Francesconi (“Executive”). 
 Section 1. Non-Competition; Non-Solicitation. 
 (a) During the period beginning on the “Effective Date,” as that term is defined in the Transitional Compensation Agreement of
even date herewith, and continuing while Executive is serving as an executive officer of the Company and for one year following the termination of Executive’s employment with the Company, any successor thereto, and its or their subsidiaries
(the “Noncompetition Period”), if such termination of employment occurs within one year after the Effective Date and Executive becomes entitled to receive the “Non-Compete Payment” as defined in Section 5 of the Transitional
Compensation Agreement, Executive will not, within fifty (50) miles of the Company’s headquarters in Rockford, Illinois as of the Effective Date, engage in “Competition” with the Company. For purposes of this Confidentiality and
Non-Competition Agreement, Competition by Executive shall mean Executive’s: 
 (i) engaging in, including without
limitation consulting or start-up activities for Executive’s own account or any third party, the business of commercial banking (including trust and asset management and mortgage banking); or 
 (ii) becoming interested in, or otherwise directly or indirectly being employed by or acting as a consultant or lender to, or render any
services to, or being a director, officer, employee, principal, agent, stockholder, manager, member, owner or partner of, employer of, or permitting his name to be used in connection with the activities of any other business or organization (a
“Competing Business”) which engages in, or is preparing to engage in, the business of commercial banking (including trust and asset management and mortgage banking); provided, however, that, notwithstanding the foregoing, it shall not be a
violation of this Section 2(a) for Executive to become the registered or beneficial owner of up to two(2%) percent of any class of the capital stock of a Competing Business registered under the Securities Exchange Act of 1934, as amended,
provided that Executive does not otherwise participate in the business of such corporation. 
 (b) during the Noncompetition
Period, Executive will not in any manner, directly or indirectly: 
 (i) solicit (or cause, or authorize, to be solicited),
divert or otherwise attempt to obtain the business of any person who is, or has at any time within three years prior to the date of such action been, a customer, supplier, licensee or business relation of the Company for any purpose which is
competitive with the Company’s business; 
 (ii) intentionally disturb or attempt to disturb in any adverse respect any
business relationship between any person and the Company; 
 (iii) solicit from any customer of the Company, or from any known
potential customer of the Company, business which has been the subject of a known written or oral bid, offer or proposal by the Company, or of substantial preparation with a view to making such a bid, proposal or offer, in any case, during the
two-year period immediately preceding the termination for any reason whatsoever of his service with the Company; 
 (iv) seek
or attempt to persuade, induce or encourage any director, officer, employee, consultant, advisor or other agent of the Company to discontinue his or her status or employment therewith or to become employed or otherwise engaged in a Competing
Business; and 
 (v) solicit or employ, or otherwise hire or engage as an employee, independent contractor, consultant,
advisor or otherwise, any person at any time within 12 months following the date of cessation of employment of such person or the termination of such person’s other status, as the case may be, with the Company. 

 Section 2. Confidentiality; Intellectual Property; Disclosure. 
 (a) Except as otherwise provided in this Confidentiality and Non-Competition Agreement, at all times hereafter, Executive shall keep
secret and retain in strictest confidence, any and all Confidential Information (as hereinafter defined) relating to the Company, and shall use such Confidential Information only in furtherance of the performance by him of his duties as an executive
officer of the Company and not for personal benefit or the benefit of any interest adverse to the interests of the Company. For purposes of this Confidentiality and Non-Competition Agreement, “Confidential Information” shall mean any
confidential or proprietary information including, without limitation, plans, specifications, models, samples, data, customer lists and customer information, computer programs and documentation, and other technical and/or business information, in
whatever form, tangible or intangible, printed, electronic or magnetic, that can be communicated by whatever means available at such time, that relates to the Company’s current business or future business contemplated during the period
Executive serves as an executive officer of the Company, products, services and/or developments, or information received from others that the Company is obligated to treat as confidential or proprietary, and Executive shall not disclose such
Confidential Information to any person other than the Company, except as may be required by law or court or administrative order (in which event Executive shall so notify the Company as promptly as practicable). Upon the termination of
Executive’s position as an executive officer of the Company for any reason, Executive shall promptly return to the Company or destroy all copies, reproductions and summaries of Confidential Information in his possession or control and erase the
same from all media in his possession or control, and, if the Company so requests, shall certify in writing that he has done so. All Confidential Information is and shall remain the property of the Company, or in the case of information that the
Company receives from a third party which it is obligated to treat as confidential, then the property of such third party. 
 (b) All Intellectual Property (as hereinafter defined) created, developed, co-developed, obtained or conceived of by Executive during the period Executive is serves as an executive officer of the Company, and all business opportunities
presented to Executive during the period Executive serves as an executive officer of the Company, shall be owned by and belong exclusively to the Company, provided that they reasonably relate to any of the business of the Company on the date of such
creation, development, obtaining or conception, and Executive shall (i) promptly disclose any such Intellectual Property or business opportunity to the Company, and (ii) promptly execute and deliver to the Company, without additional
compensation, such instruments as the Company may require from time to time to evidence its ownership of any such Intellectual Property or business opportunity (the “Intellectual Property Documents”). If the Company is unable because of
Executive’s mental or physical incapacity or for any other reason to secure Executive’s signature for any Intellectual Property Document, then Executive hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as his agent and attorney in fact, to act for and in his behalf and stead to execute and file any Intellectual Property Document and to do all other lawfully permitted acts to evidence or perfect the Company’s ownership and
rights of and to any Intellectual Property or business opportunity with the same legal force and effect as if executed by Executive. For purposes of this Confidentiality and Non-Competition Agreement, the term “Intellectual Property” means
any and all of the following and all statutory and/or common law rights throughout the world in, arising out of, or associated therewith: (i) all patents and applications therefor, including docketed patent disclosures awaiting filing,
reissues, divisions, renewals, extensions, provisionals, continuations and continuations-in-part thereof; (ii) all inventions (whether patentable or not), inventions disclosures and improvements, all trade secrets, confidential business
information (including ideas, research and development, know-how, compositions, designs, specifications, pricing and cost information and business and market plans and proposals), proprietary information, manufacturing, engineering and technical
drawings and specifications, processes, designs and technology; (iii) all works of authorship, “moral rights,” copyrights (including derivative works thereof), mask works, copyright and mask work registrations and applications
therefor; (iv) all trade names, trade dress, logos, product names, collective marks, collective membership marks, trademarks certification marks and service marks, trademark and service mark registrations and applications together with the
goodwill of the business symbolized by the names and the marks; (v) all data and related documents, object code, databases, passwords, encryption technology, firmware, development tools, files, records and data, and all media on which any of
the foregoing is recorded; (vi) any similar, corresponding or equivalent rights to any of the foregoing; (vii) all documentation related to any of the foregoing; and (viii) all goodwill associated with any of the foregoing.

  

 A-2 

 Section 3. Non-Disparagement. 
 Executive shall not, at any time from and after the Effective Date, make statements or representations, or otherwise communicate, directly
or indirectly, in writing, orally, or otherwise, or take any action which may, directly or indirectly, disparage or be damaging to the Company, its successors, subsidiaries or affiliates or their respective officers, directors, employees, advisors,
businesses or reputations, and the Company, its successors, subsidiaries and affiliates and their respective officers, employees, and agents shall not make any such statements or representations regarding Executive. Notwithstanding the foregoing,
nothing in this Agreement shall preclude Executive or any other person from making truthful statements that are required by applicable law, regulation or legal process. 
 Section 4. Cooperation With Regard to Litigation. 
 Executive agrees to cooperate
with the Company, at any time from and after the Effective Date (including following Executive’s termination of employment), by making himself available to testify on behalf of the Company or any successor, subsidiary or affiliate of the
Company, in any action, suit, or proceeding, whether civil, criminal, administrative, or investigative, and to assist the Company, or any successor, subsidiary or affiliate of the Company, in any such action, suit, or proceeding, by providing
information and meeting and consulting with the Board or its representatives or counsel, or representatives or counsel to the Company, or any subsidiary or affiliate of the Company, as may be reasonably requested and after taking into account
Executive’s responsibilities and obligations to third parties. The Company agrees to reimburse Executive, on an after-tax basis, for all expenses actually incurred in connection with his provision of testimony or assistance hereunder.

 Section 5. Covenants Reasonable. 
 Executive hereby acknowledges that the business of the Company is highly competitive. Executive further acknowledges that this Confidentiality and Non-Competition Agreement is being entered into in connection with the
Transitional Compensation Agreement, that his service to the Company will be of a special and unique character, and that he will continue to be identified personally with the Company. Executive also acknowledges that service as an executive officer
of the Company will require that he have access to some of the Company’s most highly confidential business information, trade secrets and proprietary information. The parties therefore acknowledge that the restrictions contained in Sections 1
and 2 hereof are a reasonable and necessary protection of the immediate interests of the Company, and any violation of these restrictions would cause substantial injury to the Company and that the Company would not have entered into the Transitional
Compensation Agreement and this Confidentiality and Non-Competition Agreement without receiving the additional consideration offered by Executive in binding himself to any of these restrictions. 
 Section 6. Governing Law; Consent to Jurisdiction; Injunctive Relief. 
 This Confidentiality and Non-Competition Agreement shall be governed by, and construed and enforced in accordance with, the laws of the
State of Illinois, without regard to its conflict of laws provisions. In the event of a breach or threatened breach by Executive of any of these restrictions, the Company shall be entitled to apply to any court of competent jurisdiction for an
injunction restraining Executive from such breach or threatened breach; provided, however, that the right to apply for an injunction shall not be construed as prohibiting the Company from pursuing any other available remedies for such breach or
threatened breach. 
 Section 7. Notices. 
 Unless otherwise provided herein, any notice, exercise of rights or other communication required or permitted to be given hereunder shall
be in writing and shall be given by overnight delivery service such as Federal Express, telecopy (or like transmission) or personal delivery against receipt, or mailed by registered or certified mail (return receipt requested), to the party to whom
it is given at such party’s address set forth below such party’s name on the signature page or such other address as such party may hereafter specify by notice to the other party hereto. Any notice or other communication shall be deemed to
have been given as of the date so personally delivered or transmitted by telecopy or like transmission or on the next business day when sent by overnight delivery service. 
  

 A-3 

 Section 8. Amendment. 
 This Confidentiality and Non-Competition Agreement may be amended, modified, superseded or canceled, and the terms and covenants hereof
may be waived, only by a written instrument executed by both of the parties hereto, or in the case of a waiver, by the party waiving compliance. The failure of either party at any time or times to require performance of any provision hereof shall in
no manner affect the right at a later time to enforce the same. 
 Section 9. Binding Effect. 
 This Confidentiality and Non-Competition Agreement is not assignable by Executive. This Confidentiality and Non-Competition Agreement
shall be binding upon and inure to the benefit of the Company and any successor organizations which shall succeed to the Company by merger or consolidation or operation of law or otherwise, or by acquisition of all or substantially all of the assets
of the Company. 
 Section 10. Severability. 
 Executive acknowledges and agrees that the restrictive covenants and agreements contained herein (the “Restrictive Covenants”)
are reasonable and valid in geographic and temporal scope and in all other respects, and do not impose limitations greater than that are necessary to protect the goodwill, the confidential information and any other business interests of the Company,
or any of its successors or assigns. If, however, any court subsequently determines that any of such covenants or agreements, or any part thereof, is invalid or unenforceable, the remainder of such covenants and agreements shall not thereby be
affected and shall be given full effect without regard to the invalid portions thereof. In addition, if any court construes any of the Restrictive Covenants, or any part thereof, to be unenforceable because of the duration of such provision or the
area covered thereby, such court shall have the power to reduce the duration or area of such provision and, in its reduced form, such provision shall then be enforceable and shall be enforced. 
 Section 11. Execution in Counterparts. 
 This Confidentiality and Non-Competition Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one and the same instrument.

 Section 12. Entire Agreement. 
 This Confidentiality and Non-Competition Agreement (together with applicable provisions of the Transitional Compensation Agreement) sets forth the entire agreement, and supersedes all prior agreements and any other
agreement between the parties and understandings, both written and oral, between the parties with respect to the subject matter hereof as applicable to any period after the Effective Date (except for other agreements relating to confidentiality,
proprietary information and intellectual property as may be entered into by Executive and the Company or any subsidiary or affiliate). 
 Section 13. Titles and Headings. 
 Titles and headings to Sections herein are for purposes of reference
only, and shall in no way limit, define or otherwise affect the meaning or interpretation of any of the provisions of this Confidentiality and Non-Competition Agreement. 
 Section 14. Conflicts of Interest; Representations and Warranties. 
 Executive
specifically covenants, warrants and represents to the Company that he has the full, complete and entire right and authority to enter into this Confidentiality and Non-Competition Agreement, that he has no agreement, duty, commitment or
responsibility or obligation of any kind or nature whatsoever with any corporation, partnership, firm, company, joint venture 

  

 A-4 

 
or other person which would conflict in any manner whatsoever with any of his duties, obligations or responsibilities to the Company pursuant to this
Confidentiality and Non-Competition Agreement or which could interfere with Executive’s performance under this Confidentiality and Non-Competition Agreement, that he is not in possession of any document or other tangible property of any other
person of a confidential or proprietary nature which would conflict in any manner whatsoever with any of his duties, obligations or responsibilities to the Company pursuant to this Confidentiality and Non-Competition Agreement and Executive’s
performance of his obligations to the Company will not breach any agreement by which Executive is bound not to disclose any proprietary information, and that he is fully ready, willing and able to perform each and all of his duties, obligations and
responsibilities pursuant to this Confidentiality and Non-Competition Agreement. 
 IN WITNESS WHEREOF, the undersigned have executed this
Confidentiality and Non-Competition Agreement. 
  

			
	
	 
	Name:	 	Guy Francesconi
	Address:	 	[employee address]
	
	AMCORE FINANCIAL, INC.
		
	By:	 	 
	Name:	 	Lori M. Burke
	Title:	 	SVP Administrative Services
	Address:	 	 AMCORE Financial, Inc.
 501 Seventh Street

Rockford, Illinois 61104

  

 A-5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]